References
1. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138: 271-281.
2. Papatheodorou K, Banach M, Bekiari E, et al. Complications of Diabetes 2017. J Diabetes Res. 2018;2018: 3086167.
3. Bakker K, van Houtum WH, Riley PC. 2005: The International Diabetes Federation focuses on the diabetic foot. Curr Diab Rep. 2005;5(6): 436-440.
4. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. New Engl J Med. 2017;376(24): 2367-2375.
5. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50(1): 18-25.
6. Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care. 2001;24(1): 84-88.
7. Wagner FW, Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2): 64-122.
8. Pendsey SP. Understanding diabetic foot. Int J Diabetes Dev Ctries. 2010;30(2): 75-79.
9. Jeon BJ, Choi HJ, Kang JS, et al. Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation. Int Wound J. 2017;14(3): 537-545.
10. Massara M, De Caridi G, Serra R, et al. The role of procalcitonin as a marker of diabetic foot ulcer infection. International Wound Journal. 2017;14(1): 31-34.
11. Coverdale JPC, Katundu KGH, Sobczak AIS, et al. Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding. Prostaglandins Leukot Essent Fatty Acids. 2018;135: 147-157.
12. Menon B, Ramalingam K, Krishna V. Study of Ischemia Modified Albumin as a Biomarker in Acute Ischaemic Stroke. Ann Neurosci. 2018;25(4): 187-190.
13. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers. 2008;24(6): 311-317.
14. Ghosh K, Muddeshwar MG, Ghosh K. Ischemia Modified Albumin Test to Detect Early Diabetic Complications. Am J Med Sci. 2017;354(5): 467-470.
15. Muhtaroglu S, Barlak Keti D, Unluhizarci K. Investigation of ischemia-modified albumin levels and some atherosclerosis-related serum parameters in patients with diabetic foot. Turk J Med Sci. 2016;46(1): 126-132.
16. Wagner FW, Jr. The diabetic foot. Orthopedics. 1987;10(1): 163-172.
17. Pendsey S. Classification and staging. In: Diabetic Foot. A Clinical Atlas. London, England: CRC Press; 2013.
18. Lavery LA, Armstrong DG, Peters EJ, et al. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care. 2007;30(2): 270-274.
19. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - A preliminary report. J Emerg Med. 2000;19(4): 311-315.
20. Sullivan GM, Feinn R. Using Effect Size-or Why the P Value Is Not Enough. J Grad Med Educ. 2012;4(3): 279-282.
21. Guo Z, Yue C, Qian Q, et al. Factors associated with lower-extremity amputation in patients with diabetic foot ulcers in a Chinese tertiary care hospital. Int Wound J. 2019;16(6): 1304-1313.
22. Hadavand F, Amouzegar A, Amid H. Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Characteristics; a Cross Sectional Study. Arch Acad Emerg Med. 2019;7(1): 37.
23. Jeandrot A, Richard JL, Combescure C, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia. 2008;51(2): 347-352.
24. Ozkan S, Adanas C. Do Hba1c, LDL and HDL Levels Determine The Level of Amputation? Acta Medica Mediterr. 2019;35(5): 2481-2485.
25. Ukinc K, Eminagaoglu S, Ersoz HO, et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine. 2009;36(3): 425-432.
26. Turk A, Nuhoglu I, Mentese A, et al. The Relationship between Diabetic Retinopathy and Serum Levels of Ischemia-Modified Albumin and Malondialdehyde. Retina-J Ret Vit Dis. 2011;31(3): 602-608.
27. Gunduz A, Mentese A, Turedi S, et al. Serum ischaemia-modified albumin increases in critical lower limb ischaemia. Emerg Med J. 2008;25(6): 351-353.
28. Muhtaroglu S, Keti DB, Unluhizarci K. Investigation of ischemia-modified albumin levels and some atherosclerosis-related serum parameters in patients with diabetic foot. Turkish Journal of Medical Sciences. 2016;46(1): 126-132.
29. Raheem GS, Al-Barzinji RM, Al-Dabbagh AA. Association of C-Reactive protein levels with Wagner grades of diabetic foot ulceration. The Third International conference of Medical Sciences. Ieaq; 2020:182-188.